[go: up one dir, main page]

AU2002315044A1 - Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry - Google Patents

Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry

Info

Publication number
AU2002315044A1
AU2002315044A1 AU2002315044A AU2002315044A AU2002315044A1 AU 2002315044 A1 AU2002315044 A1 AU 2002315044A1 AU 2002315044 A AU2002315044 A AU 2002315044A AU 2002315044 A AU2002315044 A AU 2002315044A AU 2002315044 A1 AU2002315044 A1 AU 2002315044A1
Authority
AU
Australia
Prior art keywords
organellar
proteomics
targets
mass spectrometry
therapeutic intervention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002315044A
Inventor
Robert E. Davis
Soumitra S. Ghosh
Bradford W. Gibson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Migenix Corp
Original Assignee
Mitokor Inc
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitokor Inc, University of California Berkeley, University of California San Diego UCSD filed Critical Mitokor Inc
Publication of AU2002315044A1 publication Critical patent/AU2002315044A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079—Mitochondria

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002315044A 2001-06-08 2002-06-10 Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry Abandoned AU2002315044A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29686701P 2001-06-08 2001-06-08
US60/296,867 2001-06-08
PCT/US2002/018484 WO2002101356A2 (en) 2001-06-08 2002-06-10 Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry

Publications (1)

Publication Number Publication Date
AU2002315044A1 true AU2002315044A1 (en) 2002-12-23

Family

ID=23143896

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002315044A Abandoned AU2002315044A1 (en) 2001-06-08 2002-06-10 Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry

Country Status (2)

Country Link
AU (1) AU2002315044A1 (en)
WO (1) WO2002101356A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115792205A (en) * 2022-09-06 2023-03-14 华东理工大学 Method and kit for diagnosing MIDD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840493A (en) * 1994-03-30 1998-11-24 Mitokor Mitochondrial DNA mutations that segregate with late onset diabetes mellitus
US6140067A (en) * 1999-04-30 2000-10-31 Mitokor Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus

Also Published As

Publication number Publication date
WO2002101356A3 (en) 2003-02-27
WO2002101356A2 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2003223520A8 (en) Targets for therapeutic intervention identified in the mitochondrial proteome
AU2003260773A1 (en) Mass spectrometer
AU2003240494A1 (en) Mass spectrometer with improved mass accuracy
GB0214432D0 (en) Ion mobility mass spectrometer
AU2003202080A1 (en) Mass spectrometry
AU2003247472A1 (en) Fragmentation methods for mass spectrometry
AU2003240060A1 (en) Mass spectrometry
AU2002239190A1 (en) Ion sorces
AU2003224953A1 (en) Mass spectrometer autosampler
AU2002358219A1 (en) Protein analysis using mass spectrometry
AU2003270005A1 (en) Planar flow-by-electrode capacitive electrospray ion source
AU2002321234A1 (en) Mass spectrometry device
AU2003201597A1 (en) Time-of-flight mass spectrometer
AU2002366768A1 (en) Explosive
AU2003237345A1 (en) Mass spectrometer
AU2003276409A1 (en) Mass spectrometer
AUPR474801A0 (en) Mass spectrometer
AU2003259707A1 (en) Mass spectrometry-based identification of proteins
AU2002315044A1 (en) Organellar proteomics including determination of targets for therapeutic intervention identified in the mitochondrial proteome using mass spectrometry
AU2003269910A1 (en) Time-of-flight mass spectrometers for improving resolution and mass range employing an impulse extraction ion source
AU2001259330A1 (en) Proteomic determination of protein nitrotyrosine modifications using mass spectrometry
AU2003268325A1 (en) Mass spectrometer
AU2002312446A1 (en) Improved proteomic analysis
AU2001275379A1 (en) Sdifa mass spectrometry
AU2003302180A1 (en) Miniaturized ion mobility spectrometer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase